- Filed
- Mar 26, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | FY 2024 · Mar 20, 2025 | 173.66M sh |
| Capex | FY 2024 · Dec 31, 2024 | $326K |
| Capex | FY 2024 · Dec 31, 2023 | $60K |
| Capex | FY 2024 · Dec 31, 2022 | $103K |
| Cash And Equivalents | FY 2024 · Dec 31, 2023 | $99.22M |
| Cash And Equivalents | FY 2024 · Dec 31, 2022 | $121.72M |
| Current Liabilities | FY 2024 · Dec 31, 2023 | $22.86M |
| Total Liabilities | FY 2024 · Dec 31, 2023 | $96.16M |
| Current Assets | FY 2024 · Dec 31, 2023 | $122.08M |
| Total Assets | FY 2024 · Dec 31, 2023 | $147.26M |
| Shares Diluted restated | FY 2024 · Dec 31, 2022 | 63.53M sh |
| Operating Cash Flow | FY 2024 · Dec 31, 2022 | −$77.1M |
| Eps Diluted | FY 2024 · Dec 31, 2022 | −$1.52 |
| Eps Basic | FY 2024 · Dec 31, 2022 | −$1.52 |
| Sga Expense | FY 2024 · Dec 31, 2022 | $27.02M |
| Rd Expense | FY 2024 · Dec 31, 2022 | $61.06M |
| Net Income | FY 2024 · Dec 31, 2022 | −$93.87M |
| Operating Income | FY 2024 · Dec 31, 2022 | −$87.57M |
| Cost Of Revenue | FY 2024 · Dec 31, 2022 | $0 |
| Revenue | FY 2024 · Dec 31, 2022 | $0 |
| Stockholders Equity | FY 2024 · Dec 31, 2021 | $64.41M |